Abstract
Despite widespread vaccination, B. pertussis remains one of the least controlled vaccine-preventable diseases. Although it is well known that acellular and whole cell pertussis vaccines induce distinct immune functionalities in memory cells, much less is known about the role of innate immunity in this process. In this review, we provide an overview of the known differences and similarities in innate receptors, innate immune cells and inflammatory signalling pathways induced by the pertussis vaccines either licensed or in development and compare this to primary infection with B. pertussis. Despite the crucial role of innate immunity in driving memory responses to B. pertussis, it is clear that a significant knowledge gap remains in our understanding of the early innate immune response to vaccination and infection. Such knowledge is essential to develop the next generation of pertussis vaccines with improved host defense against B. pertussis.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Abramson T, Kedem H, Relman DA (2001) Proinflammatory and proapoptotic activities associated with Bordetella pertussis filamentous hemagglutinin. Infect Immun 69(4):2650–2658. https://doi.org/10.1128/IAI.69.4.2650-2658.2001
Abramson T, Kedem H, Relman DA (2008) Modulation of the NF-kappaB pathway by Bordetella pertussis filamentous hemagglutinin. PLoS One 3(11):e3825. https://doi.org/10.1371/journal.pone.0003825
Ahmed R, Gray D (1996) Immunological memory and protective immunity: understanding their relation. Science 272(5258):54–60
Allen AC, Wilk MM, Misiak A, Borkner L, Murphy D, Mills KHG (2018) Sustained protective immunity against Bordetella pertussis nasal colonization by intranasal immunization with a vaccine-adjuvant combination that induces IL-17-secreting TRM cells. Mucosal Immunol 11(6):1763–1776. https://doi.org/10.1038/s41385-018-0080-x
Andreasen C, Carbonetti NH (2009) Role of neutrophils in response to Bordetella pertussis infection in mice. Infect Immun 77(3):1182–1188. https://doi.org/10.1128/IAI.01150-08
Asgarian-Omran H, Amirzargar AA, Zeerleder S, Mahdavi M, van Mierlo G, Solati S, Jeddi-Tehrani M, Rabbani H, Aarden L, Shokri F (2015) Interaction of Bordetella pertussis filamentous hemagglutinin with human TLR2: identification of the TLR2-binding domain. APMIS 123(2):156–162. https://doi.org/10.1111/apm.12332
Ashworth LA, Irons LI, Dowsett AB (1982) Antigenic relationship between serotype-specific agglutinogen and fimbriae of Bordetella pertussis. Infect Immun 37(3):1278–1281
Athie-Morales V, Smits HH, Cantrell DA, Hilkens CM (2004) Sustained IL-12 signaling is required for Th1 development. J Immunol 172(1):61–69
Ausiello CM, Lande R, la Sala A, Urbani F, Cassone A (1998) Cell-mediated immune response of healthy adults to Bordetella pertussis vaccine antigens. J Infect Dis 178(2):466–470
Ausiello CM, Fedele G, Urbani F, Lande R, Di Carlo B, Cassone A (2002) Native and genetically inactivated pertussis toxins induce human dendritic cell maturation and synergize with lipopolysaccharide in promoting T helper type 1 responses. J Infect Dis 186(3):351–360. https://doi.org/10.1086/341510
Banus HA, Vandebriel RJ, de Ruiter H, Dormans JA, Nagelkerke NJ, Mooi FR, Hoebee B, van Kranen HJ, Kimman TG (2006) Host genetics of Bordetella pertussis infection in mice: significance of toll-like receptor 4 in genetic susceptibility and pathobiology. Infect Immun 74(5):2596–2605. https://doi.org/10.1128/IAI.74.5.2596-2605.2006
Banus S, Pennings J, Vandebriel R, Wester P, Breit T, Mooi F, Hoebee B, Kimman T (2007) Lung response to Bordetella pertussis infection in mice identified by gene-expression profiling. Immunogenetics 59(7):555–564. https://doi.org/10.1007/s00251-007-0227-5
Barbic J, Leef MF, Burns DL, Shahin RD (1997) Role of gamma interferon in natural clearance of Bordetella pertussis infection. Infect Immun 65(12):4904–4908
Barnard A, Mahon BP, Watkins J, Redhead K, Mills KH (1996) Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1, Th2 or Th0. Immunology 87(3):372–380
Bart MJ, Harris SR, Advani A, Arakawa Y, Bottero D, Bouchez V, Cassiday PK, Chiang CS, Dalby T, Fry NK, Gaillard ME, van Gent M, Guiso N, Hallander HO, Harvill ET, He Q, van der Heide HG, Heuvelman K, Hozbor DF, Kamachi K, Karataev GI, Lan R, Lutynska A, Maharjan RP, Mertsola J, Miyamura T, Octavia S, Preston A, Quail MA, Sintchenko V, Stefanelli P, Tondella ML, Tsang RS, Xu Y, Yao SM, Zhang S, Parkhill J, Mooi FR (2014) Global population structure and evolution of Bordetella pertussis and their relationship with vaccination. MBio 5(2):e01074. https://doi.org/10.1128/mBio.01074-14
Barton ES, White DW, Cathelyn JS, Brett-McClellan KA, Engle M, Diamond MS, Miller VL, Virgin HW (2007) Herpesvirus latency confers symbiotic protection from bacterial infection. Nature 447(7142):326–329. https://doi.org/10.1038/nature05762
Behr MA, Divangahi M (2015) Freund’s adjuvant, NOD2 and mycobacteria. Curr Opin Microbiol 23:126–132. https://doi.org/10.1016/j.mib.2014.11.015
Benz R, Maier E, Ladant D, Ullmann A, Sebo P (1994) Adenylate cyclase toxin (CyaA) of Bordetella pertussis. Evidence for the formation of small ion-permeable channels and comparison with HlyA of Escherichia coli. J Biol Chem 269(44):27231–27239
Bernard NJ, Finlay CM, Tannahill GM, Cassidy JP, O’Neill LA, Mills KH (2015) A critical role for the TLR signaling adapter Mal in alveolar macrophage-mediated protection against Bordetella pertussis. Mucosal Immunol 8(5):982–992. https://doi.org/10.1038/mi.2014.125
Berstad AK, Oftung F, Korsvold GE, Haugen IL, Froholm LO, Holst J, Haneberg B (2000) Induction of antigen-specific T cell responses in human volunteers after intranasal immunization with a whole-cell pertussis vaccine. Vaccine 18(22):2323–2330
Beveridge TJ (1999) Structures of gram-negative cell walls and their derived membrane vesicles. J Bacteriol 181(16):4725–4733
Boehm DT, Hall JM, Wong TY, DiVenere AM, Sen-Kilic E, Bevere JR, Bradford SD, Blackwood CB, Elkins CM, DeRoos KA, Gray MC, Cooper CG, Varney ME, Maynard JA, Hewlett EL, Barbier M, Damron FH (2018) Evaluation of adenylate cyclase toxoid antigen in acellular pertussis vaccines by using a Bordetella pertussis challenge model in mice. Infect Immun 86(10). https://doi.org/10.1128/IAI.00857-17
Bordet J, Genou O (1906) Le microbe de la coqueluche. Ann Inst Pasteur 20:731–741
Bottero D, Gaillard ME, Zurita E, Moreno G, Martinez DS, Bartel E, Bravo S, Carriquiriborde F, Errea A, Castuma C, Rumbo M, Hozbor D (2016) Characterization of the immune response induced by pertussis OMVs-based vaccine. Vaccine 34(28):3303–3309. https://doi.org/10.1016/j.vaccine.2016.04.079
Braat H, McGuirk P, Ten Kate FJ, Huibregtse I, Dunne PJ, Hommes DW, Van Deventer SJ, Mills KH (2007) Prevention of experimental colitis by parenteral administration of a pathogen-derived immunomodulatory molecule. Gut 56(3):351–357. https://doi.org/10.1136/gut.2006.099861
Bromberg K, Tannis G, Steiner P (1991) Detection of Bordetella pertussis associated with the alveolar macrophages of children with human immunodeficiency virus infection. Infect Immun 59(12):4715–4719
Brouillette E, Hyodo M, Hayakawa Y, Karaolis DK, Malouin F (2005) 3′,5′-cyclic diguanylic acid reduces the virulence of biofilm-forming Staphylococcus aureus strains in a mouse model of mastitis infection. Antimicrob Agents Chemother 49(8):3109–3113. https://doi.org/10.1128/AAC.49.8.3109-3113.2005
Brubaker SW, Bonham KS, Zanoni I, Kagan JC (2015) Innate immune pattern recognition: a cell biological perspective. Annu Rev Immunol 33:257–290. https://doi.org/10.1146/annurev-immunol-032414-112240
Brummelman J, Helm K, Hamstra HJ, van der Ley P, Boog CJ, Han WG, van Els CA (2015) Modulation of the CD4(+) T cell response after acellular pertussis vaccination in the presence of TLR4 ligation. Vaccine 33(12):1483–1491. https://doi.org/10.1016/j.vaccine.2015.01.063
Burdette DL, Vance RE (2013) STING and the innate immune response to nucleic acids in the cytosol. Nat Immunol 14(1):19–26. https://doi.org/10.1038/ni.2491
Byrne P, McGuirk P, Todryk S, Mills KH (2004) Depletion of NK cells results in disseminating lethal infection with Bordetella pertussis associated with a reduction of antigen-specific Th1 and enhancement of Th2, but not Tr1 cells. Eur J Immunol 34(9):2579–2588. https://doi.org/10.1002/eji.200425092
Campbell JD (2017) Development of the CpG adjuvant 1018: a case study. Methods Mol Biol 1494:15–27. https://doi.org/10.1007/978-1-4939-6445-1_2
Carbonetti NH, Artamonova GV, Van Rooijen N, Ayala VI (2007) Pertussis toxin targets airway macrophages to promote Bordetella pertussis infection of the respiratory tract. Infect Immun 75(4):1713–1720. https://doi.org/10.1128/IAI.01578-06
Caroff M, Karibian D, Cavaillon JM, Haeffner-Cavaillon N (2002) Structural and functional analyses of bacterial lipopolysaccharides. Microbes Infect 4(9):915–926
Cauchi S, Locht C (2018) Non-specific effects of live attenuated pertussis vaccine against heterologous infectious and inflammatory diseases. Front Immunol 9:2872. https://doi.org/10.3389/fimmu.2018.02872
Cerny O, Kamanova J, Masin J, Bibova I, Skopova K, Sebo P (2015) Bordetella pertussis adenylate cyclase toxin blocks induction of bactericidal nitric oxide in macrophages through cAMP-dependent activation of the SHP-1 phosphatase. J Immunol 194(10):4901–4913. https://doi.org/10.4049/jimmunol.1402941
Chen F, Wu W, Millman A, Craft JF, Chen E, Patel N, Boucher JL, Urban JF Jr, Kim CC, Gause WC (2014) Neutrophils prime a long-lived effector macrophage phenotype that mediates accelerated helminth expulsion. Nat Immunol 15(10):938–946. https://doi.org/10.1038/ni.2984
Cherry JD (2015) The history of pertussis (Whooping Cough); 1906–2015: facts, myths, and misconceptions. Curr Epidemiol Rep 2(2):120–130. https://doi.org/10.1007/s40471-015-0041-9
Clark TA (2014) Changing pertussis epidemiology: everything old is new again. J Infect Dis 209(7):978–981. https://doi.org/10.1093/infdis/jiu001
Coffman RL, Sher A, Seder RA (2010) Vaccine adjuvants: putting innate immunity to work. Immunity 33(4):492–503. https://doi.org/10.1016/j.immuni.2010.10.002
Coleman MM, Finlay CM, Moran B, Keane J, Dunne PJ, Mills KH (2012) The immunoregulatory role of CD4(+) FoxP3(+) CD25(−) regulatory T cells in lungs of mice infected with Bordetella pertussis. FEMS Immunol Med Microbiol 64(3):413–424. https://doi.org/10.1111/j.1574-695X.2011.00927.x
Coley WB (1991) The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases. 1893. Clin Orthop Relat Res 262:3–11
Consortium P (2018) PERISCOPE: road towards effective control of pertussis. Lancet Infect Dis. https://doi.org/10.1016/S1473-3099(18)30646-7
Dadaglio G, Fayolle C, Zhang X, Ryffel B, Oberkampf M, Felix T, Hervas-Stubbs S, Osicka R, Sebo P, Ladant D, Leclerc C (2014) Antigen targeting to CD11b+ dendritic cells in association with TLR4/TRIF signaling promotes strong CD8+ T cell responses. J Immunol 193(4):1787–1798. https://doi.org/10.4049/jimmunol.1302974
de Gouw D, Diavatopoulos DA, Bootsma HJ, Hermans PW, Mooi FR (2011) Pertussis: a matter of immune modulation. FEMS Microbiol Rev 35(3):441–474. https://doi.org/10.1111/j.1574-6976.2010.00257.x
de Graaf H, Gbesemete D, Gorringe AR, Diavatopoulos DA, Kester KE, Faust SN, Read RC (2017) Investigating Bordetella pertussis colonisation and immunity: protocol for an inpatient controlled human infection model. BMJ Open 7(10):e018594. https://doi.org/10.1136/bmjopen-2017-018594
Decker MD, Edwards KM (2000) Acellular pertussis vaccines. Pediatr Clin N Am 47(2):309–335
Di Luzio NR, Williams DL (1978) Protective effect of glucan against systemic Staphylococcus aureus septicemia in normal and leukemic mice. Infect Immun 20(3):804–810
Diavatopoulos DA, Edwards KM (2017) What is wrong with pertussis vaccine immunity? Why immunological memory to pertussis is failing. Cold Spring Harb Perspect Biol 9(12). https://doi.org/10.1101/cshperspect.a029553
Dieterich C, Relman DA (2011) Modulation of the host interferon response and ISGylation pathway by B. pertussis filamentous hemagglutinin. PLoS One 6(11):e27535. https://doi.org/10.1371/journal.pone.0027535
Domenech de Celles M, Magpantay FM, King AA, Rohani P (2016) The pertussis enigma: reconciling epidemiology, immunology and evolution. Proc Biol Sci 283(1822). https://doi.org/10.1098/rspb.2015.2309
Donnelly S, Loscher CE, Lynch MA, Mills KH (2001) Whole-cell but not acellular pertussis vaccines induce convulsive activity in mice: evidence of a role for toxin-induced interleukin-1beta in a new murine model for analysis of neuronal side effects of vaccination. Infect Immun 69(7):4217–4223. https://doi.org/10.1128/IAI.69.7.4217-4223.2001
Dumas A, Amiable N, de Rivero Vaccari JP, Chae JJ, Keane RW, Lacroix S, Vallieres L (2014) The inflammasome pyrin contributes to pertussis toxin-induced IL-1beta synthesis, neutrophil intravascular crawling and autoimmune encephalomyelitis. PLoS Pathog 10(5):e1004150. https://doi.org/10.1371/journal.ppat.1004150
Dunne PJ, Moran B, Cummins RC, Mills KH (2009) CD11c+CD8alpha+ dendritic cells promote protective immunity to respiratory infection with Bordetella pertussis. J Immunol 183(1):400–410. https://doi.org/10.4049/jimmunol.0900169
Dunne A, Ross PJ, Pospisilova E, Masin J, Meaney A, Sutton CE, Iwakura Y, Tschopp J, Sebo P, Mills KH (2010) Inflammasome activation by adenylate cyclase toxin directs Th17 responses and protection against Bordetella pertussis. J Immunol 185(3):1711–1719. https://doi.org/10.4049/jimmunol.1000105
Dunne A, Mielke LA, Allen AC, Sutton CE, Higgs R, Cunningham CC, Higgins SC, Mills KH (2015) A novel TLR2 agonist from Bordetella pertussis is a potent adjuvant that promotes protective immunity with an acellular pertussis vaccine. Mucosal Immunol 8(3):607–617. https://doi.org/10.1038/mi.2014.93
Eisenbarth SC, Colegio OR, O’Connor W, Sutterwala FS, Flavell RA (2008) Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453(7198):1122–1126. https://doi.org/10.1038/nature06939
Fedele G, Celestino I, Spensieri F, Frasca L, Nasso M, Watanabe M, Remoli ME, Coccia EM, Altieri F, Ausiello CM (2007) Lipooligosaccharide from Bordetella pertussis induces mature human monocyte-derived dendritic cells and drives a Th2 biased response. Microbes Infect 9(7):855–863. https://doi.org/10.1016/j.micinf.2007.03.002
Fedele G, Nasso M, Spensieri F, Palazzo R, Frasca L, Watanabe M, Ausiello CM (2008) Lipopolysaccharides from Bordetella pertussis and Bordetella parapertussis differently modulate human dendritic cell functions resulting in divergent prevalence of Th17-polarized responses. J Immunol 181(1):208–216
Fedele G, Spensieri F, Palazzo R, Nasso M, Cheung GY, Coote JG, Ausiello CM (2010) Bordetella pertussis commits human dendritic cells to promote a Th1/Th17 response through the activity of adenylate cyclase toxin and MAPK-pathways. PLoS One 5(1):e8734. https://doi.org/10.1371/journal.pone.0008734
Fedele G, Bianco M, Debrie AS, Locht C, Ausiello CM (2011) Attenuated Bordetella pertussis vaccine candidate BPZE1 promotes human dendritic cell CCL21-induced migration and drives a Th1/Th17 response. J Immunol 186(9):5388–5396. https://doi.org/10.4049/jimmunol.1003765
Fedele G, Bianco M, Ausiello CM (2013) The virulence factors of Bordetella pertussis: talented modulators of host immune response. Arch Immunol Ther Exp 61(6):445–457. https://doi.org/10.1007/s00005-013-0242-1
Ferguson RG, Simes AB (1949) BCG vaccination of Indian infants in Saskatchewan. Tubercle 30(1):5–11
Feunou PF, Bertout J, Locht C (2010) T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis. PLoS One 5(4):e10178. https://doi.org/10.1371/journal.pone.0010178
Foster SL, Hargreaves DC, Medzhitov R (2007) Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447(7147):972–978. https://doi.org/10.1038/nature05836
Gaillard ME, Bottero D, Errea A, Ormazabal M, Zurita ME, Moreno G, Rumbo M, Castuma C, Bartel E, Flores D, van der Ley P, van der Ark A, Hozbor DF (2014) Acellular pertussis vaccine based on outer membrane vesicles capable of conferring both long-lasting immunity and protection against different strain genotypes. Vaccine 32(8):931–937. https://doi.org/10.1016/j.vaccine.2013.12.048
Ganguly T, Johnson JB, Kock ND, Parks GD, Deora R (2014) The Bordetella pertussis Bps polysaccharide enhances lung colonization by conferring protection from complement-mediated killing. Cell Microbiol 16(7):1105–1118. https://doi.org/10.1111/cmi.12264
Garly ML, Martins CL, Bale C, Balde MA, Hedegaard KL, Gustafson P, Lisse IM, Whittle HC, Aaby P (2003) BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa. A non-specific beneficial effect of BCG? Vaccine 21(21–22):2782–2790
Gasperini G, Biagini M, Arato V, Gianfaldoni C, Vadi A, Norais N, Bensi G, Delany I, Pizza M, Arico B, Leuzzi R (2018) Outer membrane vesicles (OMV)-based and proteomics-driven antigen selection identifies novel factors contributing to Bordetella pertussis adhesion to epithelial cells. Mol Cell Proteomics 17(2):205–215. https://doi.org/10.1074/mcp.RA117.000045
Gaudet S, Miller-Jensen K (2016) Redefining signaling pathways with an expanding single-cell toolbox. Trends Biotechnol 34(6):458–469. https://doi.org/10.1016/j.tibtech.2016.02.009
Geurtsen J, Banus HA, Gremmer ER, Ferguson H, de la Fonteyne-Blankestijn LJ, Vermeulen JP, Dormans JA, Tommassen J, van der Ley P, Mooi FR, Vandebriel RJ (2007) Lipopolysaccharide analogs improve efficacy of acellular pertussis vaccine and reduce type I hypersensitivity in mice. Clin Vaccine Immunol 14(7):821–829. https://doi.org/10.1128/CVI.00074-07
Geurtsen J, Fransen F, Vandebriel RJ, Gremmer ER, de la Fonteyne-Blankestijn LJ, Kuipers B, Tommassen J, van der Ley P (2008) Supplementation of whole-cell pertussis vaccines with lipopolysaccharide analogs: modification of vaccine-induced immune responses. Vaccine 26(7):899–906. https://doi.org/10.1016/j.vaccine.2007.12.012
Goldman WE, Klapper DG, Baseman JB (1982) Detection, isolation, and analysis of a released Bordetella pertussis product toxic to cultured tracheal cells. Infect Immun 36(2):782–794
Greco D, Salmaso S, Mastrantonio P, Giuliano M, Tozzi AE, Anemona A, Ciofi degli Atti ML, Giammanco A, Panei P, Blackwelder WC, Klein DL, Wassilak SG (1996) A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. N Engl J Med 334(6):341–348. https://doi.org/10.1056/NEJM199602083340601
Guermonprez P, Khelef N, Blouin E, Rieu P, Ricciardi-Castagnoli P, Guiso N, Ladant D, Leclerc C (2001) The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the alpha(M)beta(2) integrin (CD11b/CD18). J Exp Med 193(9):1035–1044
Gustafsson L, Hallander HO, Olin P, Reizenstein E, Storsaeter J (1996) A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med 334(6):349–355. https://doi.org/10.1056/NEJM199602083340602
Harvill ET, Cotter PA, Miller JF (1999) Pregenomic comparative analysis between bordetella bronchiseptica RB50 and Bordetella pertussis tohama I in murine models of respiratory tract infection. Infect Immun 67(11):6109–6118
Hellwig SM, Hazenbos WL, van de Winkel JG, Mooi FR (1999) Evidence for an intracellular niche for Bordetella pertussis in broncho-alveolar lavage cells of mice. FEMS Immunol Med Microbiol 26(3–4):203–207. https://doi.org/10.1111/j.1574-695X.1999.tb01391.x
Henderson MW, Inatsuka CS, Sheets AJ, Williams CL, Benaron DJ, Donato GM, Gray MC, Hewlett EL, Cotter PA (2012) Contribution of Bordetella filamentous hemagglutinin and adenylate cyclase toxin to suppression and evasion of interleukin-17-mediated inflammation. Infect Immun 80(6):2061–2075. https://doi.org/10.1128/IAI.00148-12
Hendrikx LH, Schure RM, Ozturk K, de Rond LG, de Greeff SC, Sanders EA, Berbers GA, Buisman AM (2011) Different IgG-subclass distributions after whole-cell and acellular pertussis infant primary vaccinations in healthy and pertussis infected children. Vaccine 29(40):6874–6880. https://doi.org/10.1016/j.vaccine.2011.07.055
Hickey FB, Brereton CF, Mills KH (2008) Adenylate cycalse toxin of Bordetella pertussis inhibits TLR-induced IRF-1 and IRF-8 activation and IL-12 production and enhances IL-10 through MAPK activation in dendritic cells. J Leukoc Biol 84(1):234–243. https://doi.org/10.1189/jlb.0208113
Higgins SC, Lavelle EC, McCann C, Keogh B, McNeela E, Byrne P, O’Gorman B, Jarnicki A, McGuirk P, Mills KH (2003) Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology. J Immunol 171(6):3119–3127
Holst J, Martin D, Arnold R, Huergo CC, Oster P, O’Hallahan J, Rosenqvist E (2009) Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis. Vaccine 27(Suppl 2):B3–B12. https://doi.org/10.1016/j.vaccine.2009.04.071
Hoonakker ME, Verhagen LM, Hendriksen CF, van Els CA, Vandebriel RJ, Sloots A, Han WG (2015) In vitro innate immune cell based models to assess whole cell Bordetella pertussis vaccine quality: a proof of principle. Biologicals 43(2):100–109. https://doi.org/10.1016/j.biologicals.2014.12.002
Hormozi K, Parton R, Coote J (1999) Adjuvant and protective properties of native and recombinant Bordetella pertussis adenylate cyclase toxin preparations in mice. FEMS Immunol Med Microbiol 23(4):273–282. https://doi.org/10.1111/j.1574-695X.1999.tb01248.x
Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, Rock KL, Fitzgerald KA, Latz E (2008) Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 9(8):847–856. https://doi.org/10.1038/ni.1631
Hovingh ES, van Gent M, Hamstra HJ, Demkes M, Mooi FR, Pinelli E (2017) Emerging Bordetella pertussis strains induce enhanced signaling of human pattern recognition receptors TLR2, NOD2 and secretion of IL-10 by dendritic cells. PLoS One 12(1):e0170027. https://doi.org/10.1371/journal.pone.0170027
Hovingh ES, Mariman R, Solans L, Hijdra D, Hamstra HJ, Jongerius I, van Gent M, Mooi F, Locht C, Pinelli E (2018) Bordetella pertussis pertactin knock-out strains reveal immunomodulatory properties of this virulence factor. Emerg Microbes Infect 7(1):39. https://doi.org/10.1038/s41426-018-0039-8
Hozbor DF (2017) Outer membrane vesicles: an attractive candidate for pertussis vaccines. Expert Rev Vaccines 16(3):193–196. https://doi.org/10.1080/14760584.2017.1276832
Huang G, Wang Y, Chi H (2012) Regulation of TH17 cell differentiation by innate immune signals. Cell Mol Immunol 9(4):287–295. https://doi.org/10.1038/cmi.2012.10
Inatsuka CS, Julio SM, Cotter PA (2005) Bordetella filamentous hemagglutinin plays a critical role in immunomodulation, suggesting a mechanism for host specificity. Proc Natl Acad Sci U S A 102(51):18578–18583. https://doi.org/10.1073/pnas.0507910102
Inatsuka CS, Xu Q, Vujkovic-Cvijin I, Wong S, Stibitz S, Miller JF, Cotter PA (2010) Pertactin is required for Bordetella species to resist neutrophil-mediated clearance. Infect Immun 78(7):2901–2909. https://doi.org/10.1128/IAI.00188-10
James LK, Till SJ (2016) Potential mechanisms for IgG4 inhibition of immediate hypersensitivity reactions. Curr Allergy Asthma Rep 16(3):23. https://doi.org/10.1007/s11882-016-0600-2
Jongerius I, Schuijt TJ, Mooi FR, Pinelli E (2015) Complement evasion by Bordetella pertussis: implications for improving current vaccines. J Mol Med (Berl) 93(4):395–402. https://doi.org/10.1007/s00109-015-1259-1
Kachroo A, Robin GP (2013) Systemic signaling during plant defense. Curr Opin Plant Biol 16(4):527–533. https://doi.org/10.1016/j.pbi.2013.06.019
Kampmann B, Jones CE (2015) Factors influencing innate immunity and vaccine responses in infancy. Philos Trans R Soc Lond Ser B Biol Sci 370(1671). https://doi.org/10.1098/rstb.2014.0148
Karaolis DK, Newstead MW, Zeng X, Hyodo M, Hayakawa Y, Bhan U, Liang H, Standiford TJ (2007) Cyclic di-GMP stimulates protective innate immunity in bacterial pneumonia. Infect Immun 75(10):4942–4950. https://doi.org/10.1128/IAI.01762-06
Kaufmann E, Sanz J, Dunn JL, Khan N, Mendonca LE, Pacis A, Tzelepis F, Pernet E, Dumaine A, Grenier JC, Mailhot-Leonard F, Ahmed E, Belle J, Besla R, Mazer B, King IL, Nijnik A, Robbins CS, Barreiro LB, Divangahi M (2018) BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis. Cell 172(1–2):176–190 e119. https://doi.org/10.1016/j.cell.2017.12.031
Kavanagh H, Noone C, Cahill E, English K, Locht C, Mahon BP (2010) Attenuated Bordetella pertussis vaccine strain BPZE1 modulates allergen-induced immunity and prevents allergic pulmonary pathology in a murine model. Clin Exp Allergy 40(6):933–941. https://doi.org/10.1111/j.1365-2222.2010.03459.x
Kawai T, Akira S (2009) The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol 21(4):317–337. https://doi.org/10.1093/intimm/dxp017
Kawai T, Akira S (2010) The role of pattern-recognition receptors in innate immunity: update on toll-like receptors. Nat Immunol 11(5):373–384. https://doi.org/10.1038/ni.1863
King KY, Goodell MA (2011) Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response. Nat Rev Immunol 11(10):685–692. https://doi.org/10.1038/nri3062
Kleinnijenhuis J, Quintin J, Preijers F, Joosten LA, Ifrim DC, Saeed S, Jacobs C, van Loenhout J, de Jong D, Stunnenberg HG, Xavier RJ, van der Meer JW, van Crevel R, Netea MG (2012) Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc Natl Acad Sci U S A 109(43):17537–17542. https://doi.org/10.1073/pnas.1202870109
Kooijman S, Brummelman J, van Els C, Marino F, Heck AJR, van Riet E, Metz B, Kersten GFA, Pennings JLA, Meiring HD (2018) Vaccine antigens modulate the innate response of monocytes to Al(OH)3. PLoS One 13(5):e0197885. https://doi.org/10.1371/journal.pone.0197885
Krahenbuhl JL, Sharma SD, Ferraresi RW, Remington JS (1981) Effects of muramyl dipeptide treatment on resistance to infection with toxoplasma gondii in mice. Infect Immun 31(2):716–722
Krieg AM (2002) CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 20:709–760. https://doi.org/10.1146/annurev.immunol.20.100301.064842
Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA, Klinman DM (1995) CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374(6522):546–549. https://doi.org/10.1038/374546a0
Kurtz J, Franz K (2003) Innate defence: evidence for memory in invertebrate immunity. Nature 425(6953):37–38. https://doi.org/10.1038/425037a
Ladant D, Ullmann A (1999) Bordatella pertussis adenylate cyclase: a toxin with multiple talents. Trends Microbiol 7(4):172–176
Leef M, Elkins KL, Barbic J, Shahin RD (2000) Protective immunity to Bordetella pertussis requires both B cells and CD4(+) T cells for key functions other than specific antibody production. J Exp Med 191(11):1841–1852
Leininger E, Roberts M, Kenimer JG, Charles IG, Fairweather N, Novotny P, Brennan MJ (1991) Pertactin, an Arg-Gly-Asp-containing Bordetella pertussis surface protein that promotes adherence of mammalian cells. Proc Natl Acad Sci U S A 88(2):345–349
Levine MI, Sackett MF (1946) Results of BCG immunization in New York City. Am Rev Tuberc 53:517–532
Li R, Lim A, Phoon MC, Narasaraju T, Ng JK, Poh WP, Sim MK, Chow VT, Locht C, Alonso S (2010) Attenuated Bordetella pertussis protects against highly pathogenic influenza A viruses by dampening the cytokine storm. J Virol 84(14):7105–7113. https://doi.org/10.1128/JVI.02542-09
Li S, Rouphael N, Duraisingham S, Romero-Steiner S, Presnell S, Davis C, Schmidt DS, Johnson SE, Milton A, Rajam G, Kasturi S, Carlone GM, Quinn C, Chaussabel D, Palucka AK, Mulligan MJ, Ahmed R, Stephens DS, Nakaya HI, Pulendran B (2014) Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. Nat Immunol 15(2):195–204. https://doi.org/10.1038/ni.2789
Locht C, Bertin P, Menozzi FD, Renauld G (1993) The filamentous haemagglutinin, a multifaceted adhesion produced by virulent Bordetella spp. Mol Microbiol 9(4):653–660
Locht C, Papin JF, Lecher S, Debrie AS, Thalen M, Solovay K, Rubin K, Mielcarek N (2017) Live attenuated pertussis vaccine BPZE1 protects baboons against Bordetella pertussis disease and infection. J Infect Dis 216(1):117–124. https://doi.org/10.1093/infdis/jix254
Macdonald-Fyall J, Xing D, Corbel M, Baillie S, Parton R, Coote J (2004) Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens. Vaccine 22(31–32):4270–4281. https://doi.org/10.1016/j.vaccine.2004.04.033
Magalhaes JG, Philpott DJ, Nahori MA, Jehanno M, Fritz J, Le Bourhis L, Viala J, Hugot JP, Giovannini M, Bertin J, Lepoivre M, Mengin-Lecreulx D, Sansonetti PJ, Girardin SE (2005) Murine Nod1 but not its human orthologue mediates innate immune detection of tracheal cytotoxin. EMBO Rep 6(12):1201–1207. https://doi.org/10.1038/sj.embor.7400552
Mann PB, Kennett MJ, Harvill ET (2004) Toll-like receptor 4 is critical to innate host defense in a murine model of bordetellosis. J Infect Dis 189(5):833–836. https://doi.org/10.1086/381898
Manz MG, Boettcher S (2014) Emergency granulopoiesis. Nat Rev Immunol 14(5):302–314. https://doi.org/10.1038/nri3660
Marr N, Novikov A, Hajjar AM, Caroff M, Fernandez RC (2010) Variability in the lipooligosaccharide structure and endotoxicity among Bordetella pertussis strains. J Infect Dis 202(12):1897–1906. https://doi.org/10.1086/657409
Mattoo S, Miller JF, Cotter PA (2000) Role of Bordetella bronchiseptica fimbriae in tracheal colonization and development of a humoral immune response. Infect Immun 68(4):2024–2033
Mbow ML, De Gregorio E, Valiante NM, Rappuoli R (2010) New adjuvants for human vaccines. Curr Opin Immunol 22(3):411–416. https://doi.org/10.1016/j.coi.2010.04.004
McGuirk P, Mills KH (2000) Direct anti-inflammatory effect of a bacterial virulence factor: IL-10-dependent suppression of IL-12 production by filamentous hemagglutinin from Bordetella pertussis. Eur J Immunol 30(2):415–422. https://doi.org/10.1002/1521-4141(200002)30:2<415::AID-IMMU415>3.0.CO;2-X
McGuirk P, Mahon BP, Griffin F, Mills KH (1998) Compartmentalization of T cell responses following respiratory infection with Bordetella pertussis: hyporesponsiveness of lung T cells is associated with modulated expression of the co-stimulatory molecule CD28. Eur J Immunol 28(1):153–163. https://doi.org/10.1002/(SICI)1521-4141(199801)28:01<153::AID-IMMU153>3.0.CO;2-#
McGuirk P, McCann C, Mills KH (2002) Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J Exp Med 195(2):221–231
McKee AS, Munks MW, MacLeod MK, Fleenor CJ, Van Rooijen N, Kappler JW, Marrack P (2009) Alum induces innate immune responses through macrophage and mast cell sensors, but these sensors are not required for alum to act as an adjuvant for specific immunity. J Immunol 183(7):4403–4414. https://doi.org/10.4049/jimmunol.0900164
Mielcarek N, Debrie AS, Raze D, Bertout J, Rouanet C, Younes AB, Creusy C, Engle J, Goldman WE, Locht C (2006) Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough. PLoS Pathog 2(7):e65. https://doi.org/10.1371/journal.ppat.0020065
Mills KH, Barnard A, Watkins J, Redhead K (1993) Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model. Infect Immun 61(2):399–410
Misiak A, Leuzzi R, Allen AC, Galletti B, Baudner BC, D’Oro U, O’Hagan DT, Pizza M, Seubert A, Mills KHG (2017a) Addition of a TLR7 agonist to an acellular pertussis vaccine enhances Th1 and Th17 responses and protective immunity in a mouse model. Vaccine 35(39):5256–5263. https://doi.org/10.1016/j.vaccine.2017.08.009
Misiak A, Wilk MM, Raverdeau M, Mills KH (2017b) IL-17-producing innate and pathogen-specific tissue resident memory gammadelta T cells expand in the lungs of Bordetella pertussis-infected mice. J Immunol 198(1):363–374. https://doi.org/10.4049/jimmunol.1601024
Moreno G, Errea A, Van Maele L, Roberts R, Leger H, Sirard JC, Benecke A, Rumbo M, Hozbor D (2013) Toll-like receptor 4 orchestrates neutrophil recruitment into airways during the first hours of Bordetella pertussis infection. Microbes Infect 15(10–11):708–718. https://doi.org/10.1016/j.micinf.2013.06.010
Munoz N, Van Maele L, Marques JM, Rial A, Sirard JC, Chabalgoity JA (2010) Mucosal administration of flagellin protects mice from Streptococcus pneumoniae lung infection. Infect Immun 78(10):4226–4233. https://doi.org/10.1128/IAI.00224-10
Nasso M, Fedele G, Spensieri F, Palazzo R, Costantino P, Rappuoli R, Ausiello CM (2009) Genetically detoxified pertussis toxin induces Th1/Th17 immune response through MAPKs and IL-10-dependent mechanisms. J Immunol 183(3):1892–1899. https://doi.org/10.4049/jimmunol.0901071
Netea MG, van Crevel R (2014) BCG-induced protection: effects on innate immune memory. Semin Immunol 26(6):512–517. https://doi.org/10.1016/j.smim.2014.09.006
Netea MG, Joosten LA, Latz E, Mills KH, Natoli G, Stunnenberg HG, O’Neill LA, Xavier RJ (2016) Trained immunity: a program of innate immune memory in health and disease. Science 352(6284):aaf1098. https://doi.org/10.1126/science.aaf1098
Obermoser G, Presnell S, Domico K, Xu H, Wang Y, Anguiano E, Thompson-Snipes L, Ranganathan R, Zeitner B, Bjork A, Anderson D, Speake C, Ruchaud E, Skinner J, Alsina L, Sharma M, Dutartre H, Cepika A, Israelsson E, Nguyen P, Nguyen QA, Harrod AC, Zurawski SM, Pascual V, Ueno H, Nepom GT, Quinn C, Blankenship D, Palucka K, Banchereau J, Chaussabel D (2013) Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines. Immunity 38(4):831–844. https://doi.org/10.1016/j.immuni.2012.12.008
O’Garra A (1998) Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8(3):275–283
Osicka R, Osickova A, Hasan S, Bumba L, Cerny J, Sebo P (2015) Bordetella adenylate cyclase toxin is a unique ligand of the integrin complement receptor 3. elife 4:e10766. https://doi.org/10.7554/eLife.10766
Paik D, Monahan A, Caffrey DR, Elling R, Goldman WE, Silverman N (2017) SLC46 family transporters facilitate cytosolic innate immune recognition of monomeric peptidoglycans. J Immunol 199(1):263–270. https://doi.org/10.4049/jimmunol.1600409
Phongsisay V, Iizasa E, Hara H, Yoshida H (2017) Pertussis toxin targets the innate immunity through DAP12, FcRgamma, and MyD88 adaptor proteins. Immunobiology 222(4):664–671. https://doi.org/10.1016/j.imbio.2016.12.004
Pichichero ME, Casey JR, Almudevar A, Basha S, Surendran N, Kaur R, Morris M, Livingstone AM, Mosmann TR (2016) Functional immune cell differences associated with low vaccine responses in infants. J Infect Dis 213(12):2014–2019. https://doi.org/10.1093/infdis/jiw053
Pillsbury A, Quinn HE, McIntyre PB (2014) Australian vaccine preventable disease epidemiological review series: pertussis, 2006-2012. Commun Dis Intell Q Rep 38(3):E179–E194
Place DE, Muse SJ, Kirimanjeswara GS, Harvill ET (2014) Caspase-1-independent interleukin-1beta is required for clearance of Bordetella pertussis infections and whole-cell vaccine-mediated immunity. PLoS One 9(9):e107188. https://doi.org/10.1371/journal.pone.0107188
Plotkin SA (2014) The pertussis problem. Clin Infect Dis 58(6):830–833. https://doi.org/10.1093/cid/cit934
Powlesland AS, Ward EM, Sadhu SK, Guo Y, Taylor ME, Drickamer K (2006) Widely divergent biochemical properties of the complete set of mouse DC-SIGN-related proteins. J Biol Chem 281(29):20440–20449. https://doi.org/10.1074/jbc.M601925200
Pulendran B (2009) Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology. Nat Rev Immunol 9(10):741–747. https://doi.org/10.1038/nri2629
Pulendran B (2014) Systems vaccinology: probing humanity’s diverse immune systems with vaccines. Proc Natl Acad Sci U S A 111(34):12300–12306. https://doi.org/10.1073/pnas.1400476111
Pulendran B, Tang H, Manicassamy S (2010) Programming dendritic cells to induce T(H)2 and tolerogenic responses. Nat Immunol 11(8):647–655. https://doi.org/10.1038/ni.1894
Queenan AM, Dowling DJ, Cheng WK, Fae K, Fernandez J, Flynn PJ, Joshi S, Brightman SE, Ramirez J, Serroyen J, Wiertsema S, Fortanier A, van den Dobbelsteen G, Levy O, Poolman J (2019) Increasing FIM2/3 antigen-content improves efficacy of Bordetella pertussis vaccines in mice in vivo without altering vaccine-induced human reactogenicity biomarkers in vitro. Vaccine 37(1):80–89. https://doi.org/10.1016/j.vaccine.2018.11.028
Quintin J, Saeed S, Martens JHA, Giamarellos-Bourboulis EJ, Ifrim DC, Logie C, Jacobs L, Jansen T, Kullberg BJ, Wijmenga C, Joosten LAB, Xavier RJ, van der Meer JWM, Stunnenberg HG, Netea MG (2012) Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes. Cell Host Microbe 12(2):223–232. https://doi.org/10.1016/j.chom.2012.06.006
Raeven RH, Brummelman J, Pennings JL, Nijst OE, Kuipers B, Blok LE, Helm K, van Riet E, Jiskoot W, van Els CA, Han WG, Kersten GF, Metz B (2014) Molecular signatures of the evolving immune response in mice following a Bordetella pertussis infection. PLoS One 9(8):e104548. https://doi.org/10.1371/journal.pone.0104548
Raeven RH, van der Maas L, Tilstra W, Uittenbogaard JP, Bindels TH, Kuipers B, van der Ark A, Pennings JL, van Riet E, Jiskoot W, Kersten GF, Metz B (2015) Immunoproteomic profiling of Bordetella pertussis outer membrane vesicle vaccine reveals broad and balanced humoral immunogenicity. J Proteome Res 14(7):2929–2942. https://doi.org/10.1021/acs.jproteome.5b00258
Raeven RH, Brummelman J, Pennings JL, van der Maas L, Tilstra W, Helm K, van Riet E, Jiskoot W, van Els CA, Han WG, Kersten GF, Metz B (2016) Bordetella pertussis outer membrane vesicle vaccine confers equal efficacy in mice with milder inflammatory responses compared to a whole-cell vaccine. Sci Rep 6:38240. https://doi.org/10.1038/srep38240
Raeven RH, Brummelman J, Pennings JLA, van der Maas L, Helm K, Tilstra W, van der Ark A, Sloots A, van der Ley P, van Eden W, Jiskoot W, van Riet E, van Els CA, Kersten GF, Han WG, Metz B (2018) Molecular and cellular signatures underlying superior immunity against Bordetella pertussis upon pulmonary vaccination. Mucosal Immunol 11(3):979–993. https://doi.org/10.1038/mi.2017.81
Rappuoli R (2000) Reverse vaccinology. Curr Opin Microbiol 3(5):445–450
Rappuoli R, Bottomley MJ, D’Oro U, Finco O, De Gregorio E (2016) Reverse vaccinology 2.0: human immunology instructs vaccine antigen design. J Exp Med 213(4):469–481. https://doi.org/10.1084/jem.20151960
Relyveld EH, Bizzini B, Gupta RK (1998) Rational approaches to reduce adverse reactions in man to vaccines containing tetanus and diphtheria toxoids. Vaccine 16(9–10):1016–1023
Renauld-Mongenie G, Cornette J, Mielcarek N, Menozzi FD, Locht C (1996) Distinct roles of the N-terminal and C-terminal precursor domains in the biogenesis of the Bordetella pertussis filamentous hemagglutinin. J Bacteriol 178(4):1053–1060
Ribes S, Meister T, Ott M, Redlich S, Janova H, Hanisch UK, Nessler S, Nau R (2014) Intraperitoneal prophylaxis with CpG oligodeoxynucleotides protects neutropenic mice against intracerebral Escherichia coli K1 infection. J Neuroinflammation 11:14. https://doi.org/10.1186/1742-2094-11-14
Roberts M, Fairweather NF, Leininger E, Pickard D, Hewlett EL, Robinson A, Hayward C, Dougan G, Charles IG (1991) Construction and characterization of Bordetella pertussis mutants lacking the vir-regulated P.69 outer membrane protein. Mol Microbiol 5(6):1393–1404
Rodrigues J, Brayner FA, Alves LC, Dixit R, Barillas-Mury C (2010) Hemocyte differentiation mediates innate immune memory in Anopheles gambiae mosquitoes. Science 329(5997):1353–1355. https://doi.org/10.1126/science.1190689
Ronchi F, Basso C, Preite S, Reboldi A, Baumjohann D, Perlini L, Lanzavecchia A, Sallusto F (2016) Experimental priming of encephalitogenic Th1/Th17 cells requires pertussis toxin-driven IL-1beta production by myeloid cells. Nat Commun 7:11541. https://doi.org/10.1038/ncomms11541
Ross PJ, Lavelle EC, Mills KH, Boyd AP (2004) Adenylate cyclase toxin from Bordetella pertussis synergizes with lipopolysaccharide to promote innate interleukin-10 production and enhances the induction of Th2 and regulatory T cells. Infect Immun 72(3):1568–1579
Ross PJ, Sutton CE, Higgins S, Allen AC, Walsh K, Misiak A, Lavelle EC, McLoughlin RM, Mills KH (2013) Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine. PLoS Pathog 9(4):e1003264. https://doi.org/10.1371/journal.ppat.1003264
Ryan M, Murphy G, Gothefors L, Nilsson L, Storsaeter J, Mills KH (1997) Bordetella pertussis respiratory infection in children is associated with preferential activation of type 1 T helper cells. J Infect Dis 175(5):1246–1250
Ryan M, McCarthy L, Rappuoli R, Mahon BP, Mills KH (1998a) Pertussis toxin potentiates Th1 and Th2 responses to co-injected antigen: adjuvant action is associated with enhanced regulatory cytokine production and expression of the co-stimulatory molecules B7-1, B7-2 and CD28. Int Immunol 10(5):651–662
Ryan M, Murphy G, Ryan E, Nilsson L, Shackley F, Gothefors L, Oymar K, Miller E, Storsaeter J, Mills KH (1998b) Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology 93(1):1–10
Sallusto F (2016) Heterogeneity of human CD4(+) T cells against microbes. Annu Rev Immunol 34:317–334. https://doi.org/10.1146/annurev-immunol-032414-112056
Samore MH, Siber GR (1996) Pertussis toxin enhanced IgG1 and IgE responses to primary tetanus immunization are mediated by interleukin-4 and persist during secondary responses to tetanus alone. Vaccine 14(4):290–297
Scanlon KM, Gau Y, Zhu J, Skerry C, Wall SM, Soleimani M, Carbonetti NH (2014) Epithelial anion transporter pendrin contributes to inflammatory lung pathology in mouse models of Bordetella pertussis infection. Infect Immun 82(10):4212–4221. https://doi.org/10.1128/IAI.02222-14
Schaeffer LM, McCormack FX, Wu H, Weiss AA (2004) Bordetella pertussis lipopolysaccharide resists the bactericidal effects of pulmonary surfactant protein a. J Immunol 173(3):1959–1965
Scheller EV, Melvin JA, Sheets AJ, Cotter PA (2015) Cooperative roles for fimbria and filamentous hemagglutinin in Bordetella adherence and immune modulation. MBio 6(3):e00500–e00515. https://doi.org/10.1128/mBio.00500-15
Schenten D, Medzhitov R (2011) The control of adaptive immune responses by the innate immune system. Adv Immunol 109:87–124. https://doi.org/10.1016/B978-0-12-387664-5.00003-0
Schiavoni I, Fedele G, Quattrini A, Bianco M, Schnoeller C, Openshaw PJ, Locht C, Ausiello CM (2014) Live attenuated B. pertussis BPZE1 rescues the immune functions of respiratory syncytial virus infected human dendritic cells by promoting Th1/Th17 responses. PLoS One 9(6):e100166. https://doi.org/10.1371/journal.pone.0100166
Schnoeller C, Roux X, Sawant D, Raze D, Olszewska W, Locht C, Openshaw PJ (2014) Attenuated Bordetella pertussis vaccine protects against respiratory syncytial virus disease via an IL-17-dependent mechanism. Am J Respir Crit Care Med 189(2):194–202. https://doi.org/10.1164/rccm.201307-1227OC
Schreibelt G, Benitez-Ribas D, Schuurhuis D, Lambeck AJ, van Hout-Kuijer M, Schaft N, Punt CJ, Figdor CG, Adema GJ, de Vries IJ (2010) Commonly used prophylactic vaccines as an alternative for synthetically produced TLR ligands to mature monocyte-derived dendritic cells. Blood 116(4):564–574. https://doi.org/10.1182/blood-2009-11-251884
Schroder NW, Schumann RR (2005) Single nucleotide polymorphisms of toll-like receptors and susceptibility to infectious disease. Lancet Infect Dis 5(3):156–164. https://doi.org/10.1016/S1473-3099(05)01308-3
Solans L, Debrie AS, Borkner L, Aguilo N, Thiriard A, Coutte L, Uranga S, Trottein F, Martin C, Mills KHG, Locht C (2018) IL-17-dependent SIgA-mediated protection against nasal Bordetella pertussis infection by live attenuated BPZE1 vaccine. Mucosal Immunol 11(6):1753–1762. https://doi.org/10.1038/s41385-018-0073-9
Souwer Y, Groot Kormelink T, Taanman-Kueter EW, Muller FJ, van Capel TMM, Varga DV, Bar-Ephraim YE, Teunissen MBM, van Ham SM, Kuijpers TW, Wouters D, Meyaard L, de Jong EC (2018) Human TH17 cell development requires processing of dendritic cell-derived CXCL8 by neutrophil elastase. J Allergy Clin Immunol 141(6):2286–2289. e2285. https://doi.org/10.1016/j.jaci.2018.01.003
Spensieri F, Fedele G, Fazio C, Nasso M, Stefanelli P, Mastrantonio P, Ausiello CM (2006) Bordetella pertussis inhibition of interleukin-12 (IL-12) p70 in human monocyte-derived dendritic cells blocks IL-12 p35 through adenylate cyclase toxin-dependent cyclic AMP induction. Infect Immun 74(5):2831–2838. https://doi.org/10.1128/IAI.74.5.2831-2838.2006
Spreafico R, Ricciardi-Castagnoli P, Mortellaro A (2010) The controversial relationship between NLRP3, alum, danger signals and the next-generation adjuvants. Eur J Immunol 40(3):638–642. https://doi.org/10.1002/eji.200940039
Stefanelli P, Fazio C, Fedele G, Spensieri F, Ausiello CM, Mastrantonio P (2009) A natural pertactin deficient strain of Bordetella pertussis shows improved entry in human monocyte-derived dendritic cells. New Microbiol 32(2):159–166
Stenger RM, Meiring HD, Kuipers B, Poelen M, van Gaans-van den Brink JA, Boog CJ, de Jong AP, van Els CA (2014) Bordetella pertussis proteins dominating the major histocompatibility complex class II-presented epitope repertoire in human monocyte-derived dendritic cells. Clin Vaccine Immunol 21(5):641–650. https://doi.org/10.1128/CVI.00665-13
Surendran N, Nicolosi T, Pichichero M (2016) Infants with low vaccine antibody responses have altered innate cytokine response. Vaccine 34(47):5700–5703. https://doi.org/10.1016/j.vaccine.2016.09.050
Surendran N, Nicolosi T, Kaur R, Morris M, Pichichero M (2017) Prospective study of the innate cellular immune response in low vaccine responder children. Innate Immun 23(1):89–96. https://doi.org/10.1177/1753425916678471
Takeda A, Hamano S, Yamanaka A, Hanada T, Ishibashi T, Mak TW, Yoshimura A, Yoshida H (2003) Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J Immunol 170(10):4886–4890
Takizawa H, Regoes RR, Boddupalli CS, Bonhoeffer S, Manz MG (2011) Dynamic variation in cycling of hematopoietic stem cells in steady state and inflammation. J Exp Med 208(2):273–284. https://doi.org/10.1084/jem.20101643
Tan T, Dalby T, Forsyth K, Halperin SA, Heininger U, Hozbor D, Plotkin S, Ulloa-Gutierrez R, Wirsing von Konig CH (2015) Pertussis across the globe: recent epidemiologic trends from 2000 to 2013. Pediatr Infect Dis J 34(9):e222–e232. https://doi.org/10.1097/INF.0000000000000795
Thorstensson R, Trollfors B, Al-Tawil N, Jahnmatz M, Bergstrom J, Ljungman M, Torner A, Wehlin L, Van Broekhoven A, Bosman F, Debrie AS, Mielcarek N, Locht C (2014) A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers. PLoS One 9(1):e83449. https://doi.org/10.1371/journal.pone.0083449
Tonon S, Goriely S, Aksoy E, Pradier O, Del Giudice G, Trannoy E, Willems F, Goldman M, De Wit D (2002) Bordetella pertussis toxin induces the release of inflammatory cytokines and dendritic cell activation in whole blood: impaired responses in human newborns. Eur J Immunol 32(11):3118–3125. https://doi.org/10.1002/1521-4141(200211)32:11<3118::AID-IMMU3118>3.0.CO;2-B
Trinchieri G, Pflanz S, Kastelein RA (2003) The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 19(5):641–644
Trollfors B, Taranger J, Lagergard T, Lind L, Sundh V, Zackrisson G, Lowe CU, Blackwelder W, Robbins JB (1995) A placebo-controlled trial of a pertussis-toxoid vaccine. N Engl J Med 333(16):1045–1050. https://doi.org/10.1056/NEJM199510193331604
Tsang RS, Lau AK, Sill ML, Halperin SA, Van Caeseele P, Jamieson F, Martin IE (2004) Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada. J Clin Microbiol 42(11):5364–5367. https://doi.org/10.1128/JCM.42.11.5364-5367.2004
Underhill DM, Goodridge HS (2012) Information processing during phagocytosis. Nat Rev Immunol 12(7):492–502. https://doi.org/10.1038/nri3244
van Beelen AJ, Zelinkova Z, Taanman-Kueter EW, Muller FJ, Hommes DW, Zaat SA, Kapsenberg ML, de Jong EC (2007) Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity 27(4):660–669. https://doi.org/10.1016/j.immuni.2007.08.013
van Loo IH, Heuvelman KJ, King AJ, Mooi FR (2002) Multilocus sequence typing of Bordetella pertussis based on surface protein genes. J Clin Microbiol 40(6):1994–2001
van Twillert I, van Gaans-van den Brink JA, Poelen MC, Helm K, Kuipers B, Schipper M, Boog CJ, Verheij TJ, Versteegh FG, van Els CA (2014) Age related differences in dynamics of specific memory B cell populations after clinical pertussis infection. PLoS One 9(1):e85227. https://doi.org/10.1371/journal.pone.0085227
Vandebriel RJ, Hellwig SM, Vermeulen JP, Hoekman JH, Dormans JA, Roholl PJ, Mooi FR (2003) Association of Bordetella pertussis with host immune cells in the mouse lung. Microb Pathog 35(1):19–29
Varney ME, Boehm DT, DeRoos K, Nowak ES, Wong TY, Sen-Kilic E, Bradford SD, Elkins C, Epperly MS, Witt WT, Barbier M, Damron FH (2018) Bordetella pertussis whole cell immunization, unlike acellular immunization, mimics naive infection by driving hematopoietic stem and progenitor cell expansion in mice. Front Immunol 9:2376. https://doi.org/10.3389/fimmu.2018.02376
Villarino Romero R, Hasan S, Fae K, Holubova J, Geurtsen J, Schwarzer M, Wiertsema S, Osicka R, Poolman J, Sebo P (2016) Bordetella pertussis filamentous hemagglutinin itself does not trigger anti-inflammatory interleukin-10 production by human dendritic cells. Int J Med Microbiol 306(1):38–47. https://doi.org/10.1016/j.ijmm.2015.11.003
Vojtova J, Kamanova J, Sebo P (2006) Bordetella adenylate cyclase toxin: a swift saboteur of host defense. Curr Opin Microbiol 9(1):69–75. https://doi.org/10.1016/j.mib.2005.12.011
Vukman KV, Ravida A, Aldridge AM, O’Neill SM (2013) Mannose receptor and macrophage galactose-type lectin are involved in Bordetella pertussis mast cell interaction. J Leukoc Biol 94(3):439–448. https://doi.org/10.1189/jlb.0313130
Wang ZY, Yang D, Chen Q, Leifer CA, Segal DM, Su SB, Caspi RR, Howard ZO, Oppenheim JJ (2006) Induction of dendritic cell maturation by pertussis toxin and its B subunit differentially initiate Toll-like receptor 4-dependent signal transduction pathways. Exp Hematol 34(8):1115–1124. https://doi.org/10.1016/j.exphem.2006.04.025
Wang X, Gray MC, Hewlett EL, Maynard JA (2015) The Bordetella adenylate cyclase repeat-in-toxin (RTX) domain is immunodominant and elicits neutralizing antibodies. J Biol Chem 290(6):3576–3591. https://doi.org/10.1074/jbc.M114.585281
Warfel JM, Merkel TJ (2013) Bordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primates. Mucosal Immunol 6(4):787–796. https://doi.org/10.1038/mi.2012.117
Warfel JM, Zimmerman LI, Merkel TJ (2014) Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc Natl Acad Sci U S A 111(2):787–792. https://doi.org/10.1073/pnas.1314688110
White MJ, Nielsen CM, McGregor RH, Riley EH, Goodier MR (2014) Differential activation of CD57-defined natural killer cell subsets during recall responses to vaccine antigens. Immunology 142(1):140–150. https://doi.org/10.1111/imm.12239
Wilk MM, Misiak A, McManus RM, Allen AC, Lynch MA, Mills KHG (2017) Lung CD4 tissue-resident memory T cells mediate adaptive immunity induced by previous infection of mice with Bordetella pertussis. J Immunol 199(1):233–243. https://doi.org/10.4049/jimmunol.1602051
Wu V, Smith AA, You H, Nguyen TA, Ferguson R, Taylor M, Park JE, Llontop P, Youngman KR, Abramson T (2016) Plasmacytoid dendritic cell-derived IFNalpha modulates Th17 differentiation during early Bordetella pertussis infection in mice. Mucosal Immunol 9(3):777–786. https://doi.org/10.1038/mi.2015.101
Yan H, KuoLee R, Tram K, Qiu H, Zhang J, Patel GB, Chen W (2009) 3′,5′-Cyclic diguanylic acid elicits mucosal immunity against bacterial infection. Biochem Biophys Res Commun 387(3):581–584. https://doi.org/10.1016/j.bbrc.2009.07.061
Zeddeman A, van Gent M, Heuvelman CJ, van der Heide HG, Bart MJ, Advani A, Hallander HO, Wirsing von Konig CH, Riffelman M, Storsaeter J, Vestrheim DF, Dalby T, Krogfelt KA, Fry NK, Barkoff AM, Mertsola J, He Q, Mooi F (2014) Investigations into the emergence of pertactin-deficient Bordetella pertussis isolates in six European countries, 1996 to 2012. Euro Surveill 19(33):pii: 20881
Zhou H, Wang Y, Lian Q, Yang B, Ma Y, Wu X, Sun S, Liu Y, Sun B (2014) Differential IL-10 production by DCs determines the distinct adjuvant effects of LPS and PTX in EAE induction. Eur J Immunol 44(5):1352–1362. https://doi.org/10.1002/eji.201343744
Zorzeto TQ, Higashi HG, da Silva MT, Carniel Ede F, Dias WO, Ramalho VD, Mazzola TN, Lima SC, Morcillo AM, Stephano MA, Antonio MA, Zanolli Mde L, Raw I, Vilela MM (2009) Immunogenicity of a whole-cell pertussis vaccine with low lipopolysaccharide content in infants. Clin Vaccine Immunol 16(4):544–550. https://doi.org/10.1128/CVI.00339-08
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Gillard, J., van Schuppen, E., Diavatopoulos, D.A. (2019). Functional Programming of Innate Immune Cells in Response to Bordetella pertussis Infection and Vaccination. In: Fedele, G., Ausiello, C. (eds) Pertussis Infection and Vaccines. Advances in Experimental Medicine and Biology(), vol 1183. Springer, Cham. https://doi.org/10.1007/5584_2019_404
Download citation
DOI: https://doi.org/10.1007/5584_2019_404
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-33248-8
Online ISBN: 978-3-030-33249-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)